- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HitGen Inc (688222)
HitGen Inc stock price live, this page displays SS 688222 stock exchange data. View the 688222 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the HitGen Inc real time stock price chart below.
What Is the HitGen Inc Stock Price Today?
The HitGen Inc stock price today is 30.10.
What Is the Stock Symbol for HitGen Inc?
The stock symbol for HitGen Inc is ""688222.""
What Stock Exchange Does HitGen Inc Trade On?
HitGen Inc is listed and trades on the Shanghai stock exchange.
Is HitGen Inc a Good Stock to Buy?
Determining whether HitGen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688222 quote. (ISIN: CNE1000040G3)
What Is the HitGen Inc Stock Price Today?
The HitGen Inc stock price today is 30.10.
What Is the Stock Symbol for HitGen Inc?
The stock symbol for HitGen Inc is ""688222.""
What Stock Exchange Does HitGen Inc Trade On?
HitGen Inc is listed and trades on the Shanghai stock exchange.
Is HitGen Inc a Good Stock to Buy?
Determining whether HitGen Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688222 quote. (ISIN: CNE1000040G3)
Shanghai
Currency in CNY
30.10
-0.14(-0.46%)
Delayed Data·
Fair Value
An estimate of a HitGen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.75
30.38
52 wk Range
11.85
42.98
688222 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a HitGen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.7530.38
52 wk Range
11.8542.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.20%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.20%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688222 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a HitGen's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
27.20
Downside
-9.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
HitGen Inc Company Profile
HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technologies; emerging technology platforms for synthetic therapeutic oligonucleotide technology; and targeted protein degradation technology. The company’s product pipeline also includes HG146, a selective HDAC inhibitor for multiple myeloma and solid tumor; HG030, a second generation NTRK/ROS1 inhibitor tablet for solid tumor; HG153 a Menin-MLL tablet; HG248; HG 381, an immune-oncology agonist for cancer, as well as HGP0508, a small molecule for anti-inflammatory therapeutics for inflammation; and HGP1069, a ROCK2 inhibitor eye drop. In addition, it offers target validation, hit identification, hit-to-lead optimization, lead optimization, preclinical studies and IND, clinical development, and integrated drug discovery services. Further, the company focuses on oncology and immuno-oncology, inflammatory and autoimmune diseases, ophthalmology, infectious, metabolic, and cardiovascular diseases. The company was incorporated in 2012 and is based in Chengdu, China.
Compare 688222 to Peers and Sector
Metrics to compare | 688222 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688222PeersSector | |
|---|---|---|---|---|
P/E Ratio | 105.9x | 52.5x | −0.5x | |
PEG Ratio | 0.90 | 0.02 | 0.00 | |
Price/Book | 8.2x | 3.4x | 2.6x | |
Price / LTM Sales | 24.2x | 5.4x | 3.3x | |
Upside (Analyst Target) | −10.1% | 19.8% | 48.1% | |
Fair Value Upside | Unlock | 9.1% | 7.7% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 27.20
(-9.63% Downside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
0.11 / --
Revenue / Forecast
143.00M / --
FAQ
What Stock Exchange Does HitGen Trade On?
HitGen is listed and trades on the Shanghai Stock Exchange.
TEST
CNY
What Is the Stock Symbol for HitGen?
The stock symbol for HitGen is "688222."
What Is the HitGen Market Cap?
As of today, HitGen market cap is 12.08B.
What Is HitGen's Earnings Per Share (TTM)?
The HitGen EPS (TTM) is 0.27.
When Is the Next HitGen Earnings Date?
HitGen will release its next earnings report on 26 Apr 2026.
From a Technical Analysis Perspective, Is 688222 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has HitGen Stock Split?
HitGen has split 0 times.
How Many Employees Does HitGen Have?
HitGen has 483 employees.
What is the current trading status of HitGen (688222)?
As of 06 Feb 2026, HitGen (688222) is trading at a price of 30.10, with a previous close of 30.24. The stock has fluctuated within a day range of 29.75 to 30.38, while its 52-week range spans from 11.85 to 42.98.
What Is HitGen (688222) Price Target According to Analysts?
The average 12-month price target for HitGen is CNY27.20, with a high estimate of CNY27.2 and a low estimate of CNY27.2. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -9.63% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.